Ionizing radiation biomarkers in epidemiological studies – An update
- Hall, Janet
- Jeggo, Penny
- West, Catharine
- Gomolka, Maria
- Quintens, Roel
- Badie, Christophe
- Laurent, Olivier
- Aerts, An
- Anastasov, Nataša
- Azimzadeh, Omid
- Azizova, Tamara
- Baatout, Sarah
- Baselet, Bjorn
- Benotmane, Mohammed
- Blanchardon, Éric
- Guéguen, Yann
- Haghdoost, Siamak
- Harms-Ringhdahl, Mats
- Hess, Julia
- Kreuzer, Michaela
- Laurier, Dominique
- Macaeva, Ellina
- Manning, Grainne
- Pernot, Eileen
- Ravanat, Jean-Luc
- Sabatier, Laure
- Tack, Karine
- Tapio, Soile
- Zitzelsberger, Horst
- Cardis, Elisabeth
DOIAbstract
International audienceRecent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of <100 mSv and dose rates of <10 mGy per year; paediatric patients studies have reported increased leukaemia and brain tumours risks after doses of 30–60 mGy from computed tomography scans. Questions arise, however, about the impact of even lower doses and dose rates where classical epidemiological studies have limited power but where subsets within the large cohorts are expected to have an increased risk. Further progress requires integration of biomarkers or bioassays ...
Add to ORKG